The first patient was dosed in the SKYBRIDGE study assessing peluntamig with Tecentriq for advanced small cell lung cancer ...

Newly discovered oncology drugs called “DNA-encoded tri-specific T-cell engagers,” or “DTriTEs,” engage the immune system ...

Scientists from the Garvan Institute of Medical Research have discovered that certain gene changes linked to leukemia may ...

A Minnesota woman was told her stage 4 colon cancer couldn’t be cured. Two years later, she’s cancer-free — and says a last-chance clinical trial gave her back her life.

May is Melanoma Awareness Month and Intermountain Health is unveiling an exciting new treatment program for Utahns with ...

Immune system scientists and computational biologists are developing a new tool to investigate how the body fights disease.

Cancer scientists engineer a new type of antibody which could be used to boost the immune systems of patients fighting disease.

IO Biotech's first-in-class vaccine performs double duty, killing cancer cells and enhancing the tumor microenvironment. A ...

Researchers at the University of Minnesota have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI) ...

Despite the massive successes of immunotherapy, which utilizes the body's immune system as a tool to fight cancer, therapy resistance is still a common treatment obstacle for many patients with solid ...

Ipilimumab, a cancer immunotherapy, reduced scar formation and promoted tissue regeneration in a mouse model of idiopathic ...

Graft vs. host disease (GVHD) is a serious condition that can occur after a stem cell transplant from a donor, where the ...